← Leaderboards
Charles Casey Cunningham
Terapio
$3,559,128
Attributed
$3,559,128
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2009–14$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,559,128 · 2
By mechanism
R44$3,000,000 · 1
R43$559,128 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Formulations”
- David Heimbrook · Leidos Biomedical Research, Inc.$143,562,560
- Sharon A Nachman · Johns Hopkins University$135,132,510
- Jaap Goudsmit · Janessen Vaccines And Prevention, Bv$70,218,020
- Thomas Macvittie · University Of Maryland Baltimore$64,108,499
- David Eric Shapiro · Harvard University D/B/A Harvard School Of Public Health$63,773,218
- Polly Chang · Sri International$60,528,575
Research focus
Drug FormulationsFuturePharmacodynamicsRecombinant ProteinsProteinsIn VivoEnzyme-Linked Immunosorbent AssayLiposomesTissuesSmall Business Innovation Research GrantRadiation ToxicityRadiationAnimalsBaseDosePublic Health RelevanceAwardAutopsyAssay DevelopmentAnimal EfficacyAcuteCommercializationData AnalysesCohort
Grant awards (5)
Development of RLIP76 protein as a Radiation Countermeasure$1,000,000
R44 · FY2014 · AI · contact PI
Development of RLIP76 protein as a Radiation Countermeasure$1,000,000
R44 · FY2013 · AI · contact PI
Development of RLIP76 protein as a Radiation Countermeasure$1,000,000
R44 · FY2012 · AI · contact PI
Development of RLIP767 as a Radiation Countermeasure$278,253
R43 · FY2010 · AI · contact PI
Development of RLIP767 as a Radiation Countermeasure$280,875
R43 · FY2009 · AI · contact PI